PPHF-CDC Partnership: Strengthening Public Health Laboratories


The major objective is to enhance and strengthen the work and functionality of public health laboratories both domestically and abroad. The overarching goal is to improve several aspects of public health laboratories. These areas include the following: improving public health laboratory infrastructure, increasing the capacity through workforce development, promoting quality laboratory practices, expanding and improving health security, promoting and supporting informatics, and enhancing communication linkages. The specific objective may include but are not limited to: 1. Assess public health infectious disease laboratory capabilities and capacities by conducting and analyzing formal and informal surveys and other methodologies. 2. Convene Committees/Task Forces/Workgroups to develop or review guidelines and recommendations on PHL laboratory capacity and quality laboratory practice. 3. Provide training and other resources to address knowledge and capacity gaps. 4. Convene forums to exchange knowledge and build communities of practice and promote the role of public health laboratories in infectious disease control, especially in emerging infectious diseases. 5. Provide programmatic and technical support to other focus areas, including policy, emergency preparedness, global health, informatics, and professional development.

General information about this opportunity
Last Known Status
Deleted 03/27/2024 (Archived.)
Program Number
Federal Agency/Office
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
A - Formula Grants
Program Accomplishments
Not applicable.
Patient Protection and Affordable Care Act (PL 111-148), Title IV, Section 4002 (Prevention and Public Health Fund) for expanded and sustained national investment in prevention and public health programs. This program is funded in part by 2015 Prevention and Public Health Funds (PPHF-2015), Section 301 and 317, 42 U.S.C 241 and 247b; Sections 301 and 317 of the Public Health Service Act (PHS Act), 42 USC, 241 and 247b as amended; and Funding is appropriated under Affordable Care Act (PL 111-148), Title IV, Section 4002 (Prevention and Public Health Fund), Title IV, Section 4002.
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Eligible applicants that can apply for this funding opportunity are listed below: o Nonprofit organizations o Small, minority, and women-owned businesses o Universities o Colleges o Research institutions o Hospitals o Community-based organizations o Faith-based organizations o Federally recognized or state-recognized American Indian/Alaska Native tribal governments o American Indian/Alaska native tribally designated organizations o Alaska Native health corporations o Urban Indian health organizations o Tribal epidemiology centers o State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) o Political subdivisions of States (in consultation with States) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via www.grants.gov.
Beneficiary Eligibility
Applicants must have experience with enhancing and strengthening the work and functionality of public health laboratories both domestically and abroad. The overarching goal is to improve several aspects of public health laboratories. The nation's public is the ultimate recipient of benefits from this program
Costs will be determined in accordance with OMB Circular No. A-87 for State and local governments. For all other nonprofit grantees, cost will be determined in accordance with HHS Regulations 45 CFR 74 Subpart Q. For-profit organizations' costs are determined in accordance with the Federal Acquisition Regulations, 48 CFR 31. OMB Circular No. A-87 applies to this program. OMB Circular No. A-87 applies to this program.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is required. n/a
Application Procedure
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. A letter of intent is required for this funding opportunity agreement. To apply for this funding opportunity use application form PHS 5161. Application forms and instructions are available on www.grants.gov and/or the CDC web site, at the following Internet address: www.cdc.gov/od/pgo/forminfo.htm. If you do not have access to the Internet, or if you have difficulty accessing the forms on-line, you may contact the CDC Procurement and Grants Office Technical Information Management Section (PGO-TIM) staff at: 770-488-2700.
Award Procedure
Applications will be evaluated for completeness and responsiveness by the agency program and CDC Procurement and Grants Office (PGO). CDC will not review incomplete and non-responsive applications. After review and approval, a notice of grant award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial award provides funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, and special conditions, if any.
July 1, 2015 to June 30, 2020
Approval/Disapproval Decision Time
From 90 to 120 days.
Not applicable.
Cooperative agreement project periods are 1 to 5 years. Subject to availability of funds, after initial awards, projects may be renewed non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government
How are proposals selected?
Applicants will be evaluated on the review criteria described in the Funding Opportunity Announcements (FOAs). In general, the review and selection process of complete and responsive applications to the FOA consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of DHHS. Refer to the FOA for additional review criteria. The budget is not scored.
How may assistance be used?
Project funds may be used for costs associated with planning, organizing, conducting, and supporting public health laboratory infrastructure programs, and for the implementation of other program elements as described in Section 050 above. CDC’s rules on allowable expenses must be followed. The purpose of the program is to enhance the work of public health laboratories in the U.S. and abroad. The program aims to promote quality public health laboratory practice, improve public health laboratory infrastructure, strengthen the public health laboratory system, and to develop a well-trained public health laboratory workforce in the U.S. and globally. It also aims to ensure laboratory preparedness for emerging infectious diseases or other biologic and chemical public health threats, promote technology transfer to ensure up-to-date technologies for the testing laboratory, and enhance communication linkages between state and local public health laboratories and the clinical laboratory testing community improvement of public health laboratory infrastructure, state-of-the-art training for the nation laboratories to be prepared in dealing with public health threats, improving laboratory leadership capabilities, enhancing inter-laboratory communications. This award will be used for direct assistance funding.
What are the requirements after being awarded this opportunity?
Performance Reports: Consult with CDC about performance monitoring activities.
Financial records, including documents to support entries on accounting records and to substantiate charges to each grant, must be kept readily available for review by personnel authorized to examine HHS grant accounts. Records must be maintained for three years after the end of a budget period. If questions still remain, such as those raised as a result of audit, related records should be retained until the matter is completely resolved.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Financial assistance is provided for a 12-month budget period with project periods of up to five years subject to the availability of funds and satisfactory progress of the grantee. Grantee should consult with PGO for additional information.
Who do I contact about this opportunity?
Regional or Local Office
For program technical assistance, contact: Shuenae Smith, Project Officer Department of Health and Human Services Centers for Disease Control and Prevention MS: V24-3, 2400 Century Parkway NE Atlanta, GA 30345 Telephone: 404-639-3008 E-mail: sfs5@cdc.gov For financial, grants management, or budget assistance, contact: Lisa DeBouse, Grants Management Specialist Department of Health and Human Services CDC Office of Grant Services 2939 Brandywine Road, MS: TV-2 Atlanta, GA 30341 Telephone: 770-488-2774 ext. 3198 E-Mail: wzn5@cdc.gov CDC Telecommunication for the hearing impaired or disabled is available: TTY (770) 488-2783
Headquarters Office
Shuenae Smith
Centers for Disease Control and Prevention
Center for Surveillance, Epidemiology and Laboratory Services (CSELS)
MS: V24-3, 2400 Century Parkway NE
Atlanta, GA 30345 US
Phone: 404) 639-3008

Brittany Dunigan-Willis
Centers for Disease Control and Prevention Center for Surveillance, Epidemiology and Laboratory Services (CSELS) MS: V24-3, 2400 Century Parkway NE
Atlanta, GA 30345 USA
Phone: 404) 498-0824
Website Address
Financial Information
Account Identification
(Formula Grants (Cooperative Agreements)) FY 18$27,552,526.00; FY 19 est $1,284,500.00; FY 20 est $0.00; FY 17$24,626,569.00; FY 16$3,216,132.00; - FY2015 actual PPHF amount awarded: $3,046,800. FY2016 actual PPHF was awarded: $3,216,132. FY2017 actual PPHF awarded: $0. FY2018 actual PPHF awarded: $2,000,000. FY2019 actual PPHF awarded: $1,284,500.
Range and Average of Financial Assistance
FY 2015 PPHF actual awarded amount $3,046,800. FY2016 anticipated PPHF awarded amount: $4,000,000; FY 2017 estimated PPHF award: $4,000,000 FY 2018 estimated PPHF award $4,000,000; FY 2019 estimated PPHF award $4,000,000 ; FY2020 estimated PPHF award amount $4,000,000. Total anticipated PPHF award from FY2015 -FY2020 : 19,046,800.
Regulations, Guidelines and Literature
42 CFR 45, basic grant administration policies of DHHS and PHS are also applicable, 46 CFR 74 and 45 CFR 92, PHS Grants Policy Statement, DHHS publication No. (OASH) 94-50,000 (Rev.) April 1, 1994


Federal Grants Resources